305 related articles for article (PubMed ID: 24499357)
1. New chitosan nanospheres for the delivery of 5-fluorouracil: preparation, characterization and in vitro studies.
Cavalli R; Leone F; Minelli R; Fantozzi R; Dianzani C
Curr Drug Deliv; 2014; 11(2):270-8. PubMed ID: 24499357
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
3. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
Nagarwal RC; Kumar R; Pandit JK
Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098
[TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study.
Nagarwal RC; Singh PN; Kant S; Maiti P; Pandit JK
Chem Pharm Bull (Tokyo); 2011; 59(2):272-8. PubMed ID: 21297311
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
Li S; Wang A; Jiang W; Guan Z
BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
[TBL] [Abstract][Full Text] [Related]
6. [Preparation and examination of BMP-2 loaded chitosan nanospheres in vitro].
Liu F; Sun J; Li YL; Chen LQ; Xie JS; Zang XL
Shanghai Kou Qiang Yi Xue; 2015 Apr; 24(2):147-50. PubMed ID: 25938141
[TBL] [Abstract][Full Text] [Related]
7. Optimization of size and encapsulation efficiency of 5-FU loaded chitosan nanoparticles by response surface methodology.
Honary S; Ebrahimi P; Hadianamrei R
Curr Drug Deliv; 2013 Dec; 10(6):742-52. PubMed ID: 24274636
[TBL] [Abstract][Full Text] [Related]
8. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
[TBL] [Abstract][Full Text] [Related]
9. Preparation of 5-fluorouracil-loaded nanoparticles and study of interaction with gastric cancer cells.
Fan YL; Fan BY; Li Q; Di HX; Meng XY; Ling N
Asian Pac J Cancer Prev; 2014; 15(18):7611-5. PubMed ID: 25292036
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
11. 5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.
Anitha A; Chennazhi KP; Nair SV; Jayakumar R
J Biomed Nanotechnol; 2012 Feb; 8(1):29-42. PubMed ID: 22515092
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
13. Chitosan/PCL nanoparticles can improve anti-neoplastic activity of 5-fluorouracil in head and neck cancer through autophagy activation.
de Lima JM; Castellano LRC; Bonan PRF; de Medeiros ES; Hier M; Bijian K; Alaoui-Jamali MA; da Cruz Perez DE; da Silva SD
Int J Biochem Cell Biol; 2021 May; 134():105964. PubMed ID: 33667680
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
15. Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan.
Chen H; Yang W; Chen H; Liu L; Gao F; Yang X; Jiang Q; Zhang Q; Wang Y
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):212-8. PubMed ID: 19545985
[TBL] [Abstract][Full Text] [Related]
16. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
17. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
Ganguly K; Kulkarni AR; Aminabhavi TM
Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
[TBL] [Abstract][Full Text] [Related]
18. Preparation of magnetite-chitosan/methylcellulose nanospheres by entrapment and adsorption techniques for targeting the anti-cancer drug 5-fluorouracil.
Şanlı O; Kahraman A; Kondolot Solak E; Olukman M
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):950-9. PubMed ID: 25677468
[TBL] [Abstract][Full Text] [Related]
19. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line.
Benito-Miguel M; Blanco MD; Gómez C
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):466-75. PubMed ID: 25976508
[TBL] [Abstract][Full Text] [Related]
20. Targeted Anticancer Drug Delivery Using Chitosan, Carbon Quantum Dots, and Aptamers to Deliver Ganoderic Acid and 5-Fluorouracil.
Mazandarani A; Taravati A; Mohammadnejad J; Yazdian F
Chem Biodivers; 2023 Sep; 20(9):e202300659. PubMed ID: 37548485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
